212 related articles for article (PubMed ID: 3381603)
1. [Immunochemical analysis of the immune response in late manifestations of Lyme borreliosis].
Wilske B; Preac-Mursic V; Schierz G; Gueye W; Herzer P; Weber K
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):549-58. PubMed ID: 3381603
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses.
Krause A; Burmester GR; Rensing A; Schoerner C; Schaible UE; Simon MM; Herzer P; Kramer MD; Wallich R
J Clin Invest; 1992 Sep; 90(3):1077-84. PubMed ID: 1522216
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of Lyme borreliosis with western blotting].
Hulínská D
Epidemiol Mikrobiol Imunol; 1997 Mar; 46(1):3-8. PubMed ID: 9162453
[TBL] [Abstract][Full Text] [Related]
5. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
Cinco M; Trevisan G; Agolzer A
Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
[TBL] [Abstract][Full Text] [Related]
7. Murine Lyme borreliosis: route of inoculation determines immune response and infectivity.
Pachner AR; Delaney E; Ricalton NS
Reg Immunol; 1992; 4(6):345-51. PubMed ID: 1297405
[TBL] [Abstract][Full Text] [Related]
8. Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
Jiang W; Luft BJ; Munoz P; Dattwyler RJ; Gorevic PD
J Immunol; 1990 Jan; 144(1):284-9. PubMed ID: 2295795
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies against particular antigens of Borrelia burgdorferi sensu stricto and their potential in the diagnosis of canine Lyme borreliosis.
Wieler LH; Szattelberger C; Weiss R; Bauerfeind R; Kutzer P; Failing K; Baljer G
Berl Munch Tierarztl Wochenschr; 1999 Dec; 112(12):465-71. PubMed ID: 10638032
[TBL] [Abstract][Full Text] [Related]
10. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
11. Antigenic variability of Borrelia burgdorferi.
Wilske B; Preac-Mursic V; Schierz G; Kühbeck R; Barbour AG; Kramer M
Ann N Y Acad Sci; 1988; 539():126-43. PubMed ID: 2461135
[TBL] [Abstract][Full Text] [Related]
12. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens.
Assous MV; Postic D; Paul G; Névot P; Baranton G
Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):261-8. PubMed ID: 8513814
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
14. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinus-borne Borrelia spirochetes.
Asbrink E
Acta Derm Venereol Suppl (Stockh); 1985; 118():1-63. PubMed ID: 3901647
[TBL] [Abstract][Full Text] [Related]
15. Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.
Wilske B; Fingerle V; Preac-Mursic V; Jauris-Heipke S; Hofmann A; Loy H; Pfister HW; Rössler D; Soutschek E
Med Microbiol Immunol; 1994 Feb; 183(1):43-59. PubMed ID: 8202030
[TBL] [Abstract][Full Text] [Related]
16. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays.
Xu Y; Bruno JF; Luft BJ
Microb Pathog; 2008; 45(5-6):403-7. PubMed ID: 18976702
[TBL] [Abstract][Full Text] [Related]
17. [Growth inhibition of Borrelia burgdorferi sensu lato by antibodies. A contribution to understanding the pathogenesis and improving diagnosis of Lyme borreliosis].
Sadziene A; Barbour AG
Wien Med Wochenschr; 1995; 145(7-8):162-5. PubMed ID: 7610664
[TBL] [Abstract][Full Text] [Related]
18. Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme disease.
Wallich R; Jahraus O; Stehle T; Tran TT; Brenner C; Hofmann H; Gern L; Simon MM
Eur J Immunol; 2003 Mar; 33(3):708-19. PubMed ID: 12616491
[TBL] [Abstract][Full Text] [Related]
19. [Lyme disease in Chile. Prevalence study in selected groups].
Neira O; Cerda C; Alvarado MA; Palma S; Abumohor P; Wainstein E; Guzmán L; Juliet C; Pérez C; Raggio X; Rojas I; Honorato H; Alcaíno H; Fredes F
Rev Med Chil; 1996 May; 124(5):537-44. PubMed ID: 9035504
[TBL] [Abstract][Full Text] [Related]
20. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
